Concordia International Corp (TSE:CXR) (NASDAQ:CXRX) insider Alternative Asset Manage Solus acquired 7,500 shares of Concordia International stock in a transaction dated Friday, November 16th. The shares were purchased at an average cost of C$24.57 per share, with a total value of C$184,275.00.

Alternative Asset Manage Solus also recently made the following trade(s):

  • On Monday, November 19th, Alternative Asset Manage Solus sold 100 shares of Concordia International stock. The stock was sold at an average price of C$26.67, for a total value of C$2,667.00.
  • On Friday, November 9th, Alternative Asset Manage Solus acquired 5,000 shares of Concordia International stock. The shares were purchased at an average cost of C$26.09 per share, with a total value of C$130,450.00.
  • On Friday, November 2nd, Alternative Asset Manage Solus acquired 400 shares of Concordia International stock. The shares were purchased at an average cost of C$26.09 per share, with a total value of C$10,436.00.
  • On Friday, October 26th, Alternative Asset Manage Solus acquired 2,000 shares of Concordia International stock. The shares were purchased at an average cost of C$27.04 per share, with a total value of C$54,080.00.
  • On Monday, October 29th, Alternative Asset Manage Solus acquired 5,000 shares of Concordia International stock. The shares were purchased at an average cost of C$27.15 per share, with a total value of C$135,750.00.
  • On Friday, October 19th, Alternative Asset Manage Solus acquired 10,200 shares of Concordia International stock. The shares were purchased at an average cost of C$25.05 per share, with a total value of C$255,510.00.
  • On Thursday, October 4th, Alternative Asset Manage Solus sold 6,500 shares of Concordia International stock. The stock was sold at an average price of C$27.35, for a total value of C$177,775.00.
  • On Thursday, September 27th, Alternative Asset Manage Solus acquired 3,000 shares of Concordia International stock. The shares were purchased at an average cost of C$23.97 per share, with a total value of C$71,910.00.
  • On Monday, October 1st, Alternative Asset Manage Solus purchased 17,100 shares of Concordia International stock. The shares were bought at an average cost of C$24.50 per share, with a total value of C$418,950.00.
  • On Monday, September 17th, Alternative Asset Manage Solus sold 1,100 shares of Concordia International stock. The shares were sold at an average price of C$26.00, for a total value of C$28,600.00.

TSE CXR traded down C$0.33 during trading hours on Wednesday, hitting C$26.22. 2,951 shares of the company traded hands, compared to its average volume of 3,611. Concordia International Corp has a twelve month low of C$19.02 and a twelve month high of C$417.00.

Separately, Bloom Burton reissued a “hold” rating on shares of Concordia International in a research report on Tuesday, September 11th.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2018/11/21/alternative-asset-manage-solus-purchases-7500-shares-of-concordia-international-corp-cxr-stock.html.

Concordia International Company Profile

Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.

Further Reading: How is the S&P 500 index different from the DJIA?

Insider Buying and Selling by Quarter for Concordia International (TSE:CXR)

Receive News & Ratings for Concordia International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia International and related companies with MarketBeat.com's FREE daily email newsletter.